Aflibercept Versus Bevacizumab and/or Ranibizumab for Recurrent Macular Edema Secondary to Central Retinal Vein Occlusion. [electronic resource]
Producer: 20191001Description: 340-345 p. digitalISSN:- 1557-7732
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Bevacizumab -- administration & dosage
- Female
- Humans
- Intravitreal Injections
- Macular Edema -- drug therapy
- Male
- Ranibizumab -- administration & dosage
- Receptors, Vascular Endothelial Growth Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Retinal Vein Occlusion -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.